Fulgent Genetics (FLGT) Change in Acquisitions & Divestments (2017 - 2026)

Fulgent Genetics has reported Change in Acquisitions & Divestments for 10 years, with the latest figure at $21.5 million in Q2 2026.

• Quarterly Change in Acquisitions & Divestments fell 64.28% year-over-year to $21.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $221.6 million (down 21.54% YoY) and the FY2025 annual result came in at $211.0 million, down 39.68% from the prior year.
• Change in Acquisitions & Divestments fell to $21.5 million in Q2 2026 per FLGT's latest filing, from $81.7 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $141.4 million in Q1 2023 and troughed at $21.5 million in Q2 2026.
• A 5-year average of $78.1 million and a median of $74.9 million in 2024 frame the typical range for Change in Acquisitions & Divestments.
• The sharpest annual moves came in 2023 and 2025: Change in Acquisitions & Divestments jumped 409.39% in 2023, then plunged 66.01% in 2025.
• Over 5 years, Change in Acquisitions & Divestments stood at $100.8 million in 2022, then soared by 30.6% to $131.7 million in 2023, then plunged by 45.48% to $71.8 million in 2024, then climbed by 8.79% to $78.1 million in 2025, then sank by 72.45% to $21.5 million in 2026.
• According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $21.5 million, $81.7 million, and $78.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.